title: Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population.
abstract: Background and Study Aims. To compare the effectiveness of two regimens, single-dose esomeprazole- and pantoprazole-based triple therapy, for Helicobacter pylori (H. pylori) eradication. Patients and Methods. A total of 453 patients were enrolled for H. pylori eradication. They were randomly assigned to either EAC group (Esomeprazole 40 mg once daily, Amoxicillin 1 g twice daily, Clarithromycin 500 mg twice daily for 7 days) or PAC group (Pantoprazole 40 mg twice daily, Amoxicillin 1 g twice daily, Clarithromycin 500 mg twice daily for 7 days). Follow-up endoscopy or urea breath test was scheduled 12-16 weeks after the eradication to evaluate the therapeutic response. Results. Higher eradication rate in EAC group than PAC group was shown by intention-to-treat analysis (EAC 72% versus PAC 55%, P < 0.05) and per-protocol analysis (EAC 91% versus PAC 72%, P < 0.05). The incidence of adverse effects (EAC 19% versus PAC 17%, P = 0.712) and the compliance (EAC 87% versus PAC 91%, P = 0.083) were comparable between these 2 groups. Conclusions. Single-dose esomeprazole-based triple therapy is effective for H. pylori eradication.
authors: Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
authors: Hsiang-Yao
authors: HY
authors: Shih
authors: Sophie S W
authors: SS
authors: Wang
authors: Chao-Hung
authors: CH
authors: Kuo
authors: Fu-Chen
authors: FC
authors: Kuo
authors: Yi-Yu
authors: YY
authors: Chen
authors: Meng-Chieh
authors: MC
authors: Wu
authors: Bi-Chuang
authors: BC
authors: Weng
authors: Yi-Chern
authors: YC
authors: Lee
authors: Chi-Tan
authors: CT
authors: Hu
authors: Deng-Chyang
authors: DC
authors: Wu
authors: Yen-Hsu
authors: YH
authors: Chen